DE EN
  • Array

    HypoPet's Technology

HypoPet’s team of innovative scientists, veterinarians and businessmen has pioneered and developed expertise and proprietary rights relating to a unique virus-like particle (VLP) vaccine nanotechnology platform. HypoPet’s VLP vaccines induce strong, long-lived and highly specific, antibody responses against the disease target, which can inhibit disease-promoting or disease-associated self-proteins.